Related Experiment Video
Updated: May 2, 2026

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
3.8K
Machine learning-based risk predictive models for depression in patients with diabetes: a systematic review and
Xingxin Cai1, Guiying Guo1,2, Jun Zhou1
1School of Nursing, Shanxi University of Chinese Medicine, Jinzhong, Shanxi, China.
Frontiers in Endocrinology
|May 1, 2026
Summary
Machine learning models show good performance in predicting depression risk for diabetes patients. However, studies need larger sample sizes and external validation for better clinical use.
Area of Science:
- Medical Informatics
- Clinical Prediction Models
- Diabetes Mellitus Research
Background:
- Inconsistent findings exist regarding machine learning (ML) models for predicting depression risk in patients with diabetes mellitus (DM).
- This systematic review addresses the need for a comprehensive evaluation of existing ML prediction models' performance, strengths, and limitations.
Purpose of the Study:
- To systematically evaluate the performance and clinical applicability of ML-based depression risk prediction models in patients with DM.
- To provide evidence-based guidance for healthcare professionals in selecting and optimizing depression prediction models.
Main Methods:
- Systematic search of PubMed, Embase, Cochrane Library, and Web of Science databases up to January 2026.
- Included studies were assessed for risk of bias and clinical applicability using PROBAST-AI.
- Pooled area under the receiver operating characteristic curve (AUC) was calculated using a random-effects model.
Main Results:
- 14 studies with 64 ML models were included; all had high risk of bias but high clinical applicability.
- Pooled AUC for best-performing models was 0.822, indicating good predictive performance.
- Deep learning models (AUC=0.802) and general ML models (AUC=0.789) outperformed traditional regression models (AUC=0.765). Logistic regression was most common.
Conclusions:
- ML models demonstrate satisfactory predictive performance for depression risk in DM patients.
- Limitations include small sample sizes and lack of external validation in most studies.
- Future research should focus on improving study design and data processing for enhanced generalizability and clinical stability.
Related Concept Videos
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: Etiology
884
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
884
Depressive Disorders: MDD and Dysthymia
1.3K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K

